Gender Dysphoria in Children and Adolescents : Parents' Perspectives

Gender Dysphoria Clinical Trial

— GeDyPar  

Official title:

Gender Dysphoria in Children and Adolescents : Parents' Perspectives

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04160364
• Other study ID #: 2019PI204
• Status: Not yet recruiting
• Start date: October 2020
• Est. completion date: January 2021

Study information

• Verified date: July 2020
• Source: Central Hospital, Nancy, France
• Contact: Eva Feigerlova, MD, PhD
• Phone: 00330383153412
• Email: e.feigerlova[@]chru-nancy.Fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Gender dysphoria is defined as a persistent incongruence between an experienced gender and the assigned sex at birth Transgender and gender nonconforming persons desire to modify their appearance to be consistent with their self-identified gender identities. In non-binary people, contrary to binary transgender persons, self-identified gender identities do not fit the classical pattern male/female.

During the last decennium, an increase in the number of young subjects, especially children and adolescents, referred to gender identity centres has been observed. A new nosological entity "rapid-onset gender dysphoria in adolescents and young adults" has recently been described in the literature, whose etiology has not been well understood.

This growing demand of adolescents and young adults observed in the recent years is not well understood.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: January 2021
• Est. primary completion date: December 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• be a parent of a child <18 years followed in the endocrinology department of the University Hospital of Nancy for gender dysphoria

• be in stable couple

• both parents agree to participate

• capacity to communicate in French

• Person who has received complete information on the organization of the research and who agreed to the exploitation of the data

Exclusion Criteria:

• Refusal to participate

• Inability to be physically, psychologically or linguistically involved in the study

Related Conditions & MeSH terms

• Depressive Disorder, Major
• Gender Dysphoria

Intervention

Other:
• qualitative study
qualitative research via guided interview

Locations

Country	Name	City	State
France	University Hospital of Nancy	Vandœuvre-lès-Nancy

Sponsors (1)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	thematic analysis	The recorde material will be coded using descriptive codes. Conceptual notes will be written, through processes of condensation, comparison and abstracting the initial notes.; Connections between notes will be noted and synthesized, and emergent themes will be developed.	one year